Table 1.
Typical prescriptions for oligometastatic sites recommended by the SABR UK Consortium.27 The dose prescribed depends on a number of factors including therapeutic goal, tumour location, histopathological subtype, and radiation dose to adjacent organs at risk
| Oligometastatic site | Dose ranges |
|---|---|
| Spine | 24 Gy in 2 fractions 27 Gy in 3 fractions 30 Gy in 5 fractions (re-irradiation) |
| Lung (peripheral, away from chest wall) | 54 Gy in 3 fractions |
| Lung (peripheral, abutting/overlapping chest wall) | 60 Gy in 5 fractions 55 Gy in 5 fractions |
| Lung (centrally located tumours, not invading central structures and not ultra-central) | 60 Gy in 8 fractions |
| Liver | 45-60 Gy in 3 fractions 50-60 Gy in 5 fractions |
| Adrenal | 30-36 Gy in 3 fractions 45 Gy in 5 fractions |